News

General Catalyst leads $168M funding round for biotech company | Health IT

By October 14, 2022No Comments

Healthcare venture capitalist firm General Catalyst has led a $168 million series B funding round for biotech company Odyssey Therapeutics.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

General Catalyst leads $168M funding round for biotech company | Health IT

Tags:

Previous PostVanderbilt adds to digital health operations leadership team | Health IT

Next PostSmall companies are most targeted in ransomware attacks, report says | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us